Beranda › Sarkoma Jaringan Lunak › California
Uji klinis Sarkoma Jaringan Lunak di California
41 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi di California.
Kota di California
- Los Angeles13 studi
- Baldwin Park7 studi
- Santa Monica7 studi
- Orange6 studi
- Mountain View6 studi
- San Francisco5 studi
- Sacramento3 studi
Teks studi resmi (Bahasa Inggris)
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
Menerima pesertaFase 1/2
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04094610DESTINY-PANTUMOUR04
- Research Site, San Diego
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07229313Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Stanford University, Palo Alto
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05732831Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Precision NextGen Oncology and Research, Beverly Hills
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
- dan 3 lainnya
Menerima pesertaFase 1
Usia 12 hingga 85 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT03715933Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT05711615Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- University of California San Francisco, San Francisco
Menerima pesertaFase 1
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06156410A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06760819Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- dan 20 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05334069Actinium Therapy for Late-stage Aggressive Sarcomas
- UCLA, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07156565STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- University of California, San Francisco, San Francisco
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06975293A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Sarcoma Oncology Center, Santa Monica
- University of California Los Angeles (UCLA) - Santa Monica Cancer Care, Santa Monica
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06263231Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- dan 6 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07059884Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07628634Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Zai Lab Site 02003, Los Angeles
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07374848Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT07064018Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
- University of California, Davis, Sacramento
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT06103669Navigation Intervention for Adolescent and Young Adult Cancer Survivors
- KP Southern California - Department of Research & Evaluation, Pasadena
Menerima peserta
Usia 21 hingga 45 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07406087Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
- City of Hope Medical Center, Duarte
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07650656A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Precision NextGen Oncology and Research Center, Beverly Hills
- Sarcoma Oncology Center, Santa Monica
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT067891725-Day Preoperative Radiation for Soft Tissue Sarcoma
- Stanford University, Palo Alto
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06087861A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
- Stanford University, Palo Alto
Menerima pesertaFase 1
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT06500819Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- dan 5 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734Prospective Registry of Histotripsy for Soft Tissue Tumors
- University of California, San Francisco, San Francisco
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07470008Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT02701153Phase II Trial of Lung Chemoemobolization
- City of Hope Medical Center, Duarte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT05672108Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Mar 2026 · NCT07447050Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- Sarcoma Oncology Center, Santa Monica
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT03016819Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
Menerima pesertaFase 1/2
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- University of Southern California - Norris Cancer Center, Los Angeles
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Des 2025 · NCT06942442A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- University of Southern California, Los Angeles
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT0694352164Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- City of Hope, Duarte
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- Stanford Hospital & Clinics, Stanford
Menerima pesertaFase 1/2
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT06298916SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
- Sarcoma Oncology Research Center, Santa Monica
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Feb 2025 · NCT03138161Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
- Sarcoma Oncology Center, Santa Monica
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Feb 2025 · NCT03886311BostonGene and Exigent Genomic INsight Study
- Stockton Hematology Oncology Medical Group, Stockton
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2025 · NCT06272864Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.